Refreshing results…
The Irreversible FGFR Inhibitor KIN-3248 Overcomes FGFR2 Kinase Domain Mutations
UploadSotorasib is a pan-RASG12C inhibitor capable of driving clinical response in NRASG12C cancers
UploadLandscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma
UploadUltrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
UploadCombined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial
UploadTargeting TBK1 to overcome resistance to cancer immunotherapy
Download from www.nature.comMissing publications? Search for publications with a matching author name.